Request Appointment
530 East 74th StreetNew York, NY 10021
Overview of Dr. Dalbagni
Dr. Guido Dalbagni is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Memorial Hospital for Cancer and allied Diseases, and Memorial Sloan Kettering Bergen. He received his medical degree from Cairo University School of Medicine and has been in practice 37 years. Dr. Dalbagni accepts several types of health insurance, listed below. He is one of 87 doctors at Memorial Sloan Kettering Cancer Center and one of 16 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Urology. He has more than 100 publications and over 500 citings.
Education & Training
NYU Grossman School of MedicineResidency, Urology, 1984 - 1988
Icahn School of Medicine at Mount Sinai (Cabrini)Residency, Surgery, 1982 - 1984
Cairo University School of MedicineClass of 1980
Certifications & Licensure
NY State Medical License 1989 - 2026
NJ State Medical License 1986 - 2025
American Board of Urology Urology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Quality of Life in Patients With Bladder Cancer
- A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer Start of enrollment: 2009 Jun 01
- Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Prospective health-related quality of life in women undergoing radical cystectomy and urinary diversion.Matthew B Clements, Kelly R Pekala, Amy L Tin, Daniel D Sjoberg, Benjamin Beech
BJU International. 2025-10-01 - Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort.Viranda H Jayalath, Melissa Assel, Gopa Iyer, Scot Niglio, Bernard H Bochner
European Urology. 2025-09-25 - Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer.Manuel R De Jesus Escano, Emily A Vertosick, Neeta D'Souza, Nicole Benfante, Andrew T Lenis
Urologic Oncology. 2025-09-01
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Aetna Whole Health Banner Health Network
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPOGreat West PPO
HealthAmerica HealthAssurance PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
